RPRX

Royalty Pharma plc
D

RPRX

62.290
USD
0.99
(1.61%)
مفتوح الان
حجم التداول
35,520
الربح لكل سهم
1
العائد الربحي
1.51
P/E
33
حجم السوق
27,736,325,758
أصول ذات صلة المقالات
المزيد

العنوان: Royalty Pharma plc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.